Adam Singer | Biomedical Sciences | Best Researcher Award

Best Researcher Award

Adam Singer
Stony Brook University, United States

Adam Singer
Affiliation Stony Brook University
Country United States
Scopus ID 7202643682
Documents 463
Citations 22,404
h-index 64
Subject Area Biomedical Sciences
Event The Scientist Global Awards
ORCID 0000-0003-4694-6152

Adam Singer is a biomedical scientist affiliated with Stony Brook University whose scholarly work encompasses translational medicine, critical care, infectious diseases, and related biomedical research. His publication record, citation impact, and sustained contributions to the scientific literature demonstrate long-term engagement with evidence-based clinical investigation and interdisciplinary collaboration. According to the Scopus database, his research output includes hundreds of indexed publications with substantial international citation impact, reflecting continued influence within the biomedical sciences community.[1]

Abstract

This article summarizes the academic profile of Adam Singer in relation to recognition for the Best Researcher Award. The profile highlights measurable scholarly indicators, institutional affiliation, publication productivity, citation performance, and sustained research engagement within biomedical sciences. The overview follows a neutral encyclopedic style and is intended to provide a concise academic summary based on publicly available scholarly information.[1]

Keywords

Biomedical Sciences, Clinical Research, Critical Care Medicine, Evidence-Based Medicine, Research Impact, Scientific Publications

Introduction

Biomedical sciences integrate laboratory discoveries with clinical applications to improve diagnosis, treatment, and patient outcomes. Researchers with sustained publication activity contribute to advancing scientific knowledge through rigorous investigation, peer-reviewed dissemination, and collaborative research initiatives. Adam Singer’s scholarly record reflects continued participation in these objectives through extensive publication and citation performance documented in international indexing services.[1]

Research Profile

Adam Singer has established a substantial academic profile supported by 463 Scopus-indexed publications, more than 22,000 citations, and an h-index of 64. These bibliometric indicators demonstrate consistent scholarly productivity together with broad visibility within biomedical research. His affiliation with Stony Brook University reflects active participation in a major research institution recognized for clinical and translational investigation.[1]

Research Contributions

The research contributions associated with Adam Singer include investigations that support evidence-based clinical practice, emergency medicine, critical care, infectious diseases, and multidisciplinary biomedical research. His publications have contributed to scientific understanding through collaborative studies, methodological rigor, and dissemination in peer-reviewed journals indexed by international databases.[2]

Publications

The publication portfolio demonstrates continuous scholarly activity across multiple biomedical disciplines. Numerous articles have appeared in internationally recognized journals, contributing to advancements in clinical medicine, patient care, biomedical methodology, and translational health research. Citation performance indicates that these publications continue to inform subsequent scientific investigations.[1][2]

Research Impact

Research impact may be assessed through citation metrics, publication quality, collaborative engagement, and influence on future investigations. Adam Singer’s extensive citation record together with a high h-index illustrates sustained scholarly recognition within the biomedical sciences community. These indicators are commonly used to evaluate scientific influence while complementing qualitative assessment of research significance.[1]

Award Suitability

Based on publicly available academic indicators, Adam Singer demonstrates characteristics generally associated with recognition for research excellence, including sustained publication productivity, international citation impact, interdisciplinary collaboration, and long-term contribution to biomedical science. Consideration for the Best Researcher Award would appropriately incorporate peer evaluation, scientific originality, publication quality, institutional contributions, and measurable research influence.[1]

Conclusion

Adam Singer’s academic record reflects an established career characterized by extensive scholarly output, international visibility, and measurable research impact within biomedical sciences. His publication history, citation performance, and institutional affiliation collectively represent a strong example of sustained scientific engagement and provide an objective foundation for academic recognition within international research award programs.[1]

References

  1. Elsevier. (2026). Scopus author details: Adam Singer, Author ID 7202643682. Scopus.
    https://www.scopus.com/pages/authors/7202643682
  2. Journal of Surgical Research. (2026). A Simple Risk Assessment Tool for Older Adult Trauma Patients—Silver Trauma Score.
    https://doi.org/10.1016/j.jss.2026.06.011
  3. The Scientist Global Awards. International Scientific Recognition Program.
    https://thescientists.net/

Vasantha Padmanabhan | Biomedical Sciences | Innovative Research Award

Innovative Research Award

Vasantha Padmanabhan — University of Michigan, United States

Vasantha Padmanabhan
Affiliation University of Michigan
Country United States
Scopus ID 7102543982
Documents 361
Citations 16,026
h-index 69
Subject Area Biomedical Sciences
Event The Scientist Global Awards

Vasantha Padmanabhan is a distinguished biomedical scientist affiliated with the University of Michigan, recognized for extensive contributions to reproductive biology, developmental physiology, endocrinology, and translational biomedical sciences. The researcher’s scholarly activities demonstrate sustained academic productivity, interdisciplinary collaboration, and measurable scientific impact through highly cited publications and influential research outputs.[1] The body of work associated with this profile reflects a significant commitment to advancing biomedical knowledge, particularly in areas related to developmental programming, reproductive endocrinology, and health outcomes associated with physiological regulation.[2]

Abstract

This article presents an academic overview of the scholarly achievements and scientific contributions of VASANTHA PADMANABHAN in the field of biomedical sciences. The researcher has established a substantial record of scientific publication, interdisciplinary collaboration, and citation impact through research focused on reproductive physiology, developmental endocrinology, fetal programming, and translational biomedical science.[1] With a Scopus h-index of 69 and more than 16,000 citations, the research profile reflects international scholarly recognition and sustained contribution to scientific advancement.[3] The body of work demonstrates significant relevance to contemporary biomedical challenges involving developmental health, endocrine regulation, and reproductive function.

Keywords

Biomedical Sciences; Reproductive Endocrinology; Developmental Programming; Translational Medicine; Physiology; Endocrine Research; Reproductive Biology; Fetal Development; Scientific Impact; Biomedical Innovation

Introduction

Biomedical sciences continue to play a central role in advancing healthcare, physiological understanding, and translational medical research. Researchers working within this interdisciplinary domain contribute to the development of evidence-based medical practices, improved disease understanding, and innovative therapeutic strategies. VASANTHA PADMANABHAN has contributed extensively to these scientific developments through research emphasizing reproductive endocrinology, developmental physiology, and long-term health outcomes associated with prenatal and developmental exposures.[2]

The research profile demonstrates sustained productivity across multiple decades, including collaborative investigations involving physiological regulation, endocrine signaling pathways, and developmental health programming. The resulting scientific publications have achieved broad academic visibility and citation influence within the biomedical sciences community.[4]

Research Profile

VASANTHA PADMANABHAN is affiliated with the University of Michigan and maintains a research portfolio centered on reproductive biology, endocrinology, developmental physiology, and translational biomedical investigations. The author profile indexed in Scopus indicates the publication of 361 scholarly documents with more than 16,026 citations and an h-index of 69, demonstrating sustained scholarly influence and international research visibility.[1]

The researcher’s scientific work has contributed to understanding the mechanisms through which developmental and environmental factors influence endocrine regulation and reproductive outcomes. These studies have relevance to both experimental biomedical science and clinical translation, supporting interdisciplinary integration between physiology, medicine, and developmental biology.[5]

Research Contributions

The scientific contributions of VASANTHA PADMANABHAN span multiple domains within biomedical sciences, particularly developmental endocrinology and reproductive physiology. Research investigations have examined the physiological consequences of prenatal hormonal influences, developmental programming mechanisms, and endocrine system regulation across the lifespan.[6]

  • Advanced understanding of developmental programming and endocrine regulation mechanisms in reproductive biology.
  • Contributions to translational biomedical research related to fetal exposure, reproductive outcomes, and physiological adaptation.
  • Interdisciplinary collaborations connecting physiology, endocrinology, and biomedical sciences.
  • Extensive publication activity contributing to highly cited biomedical literature and evidence-based scientific advancement.

These contributions have supported broader scientific understanding of endocrine health and developmental physiology while informing subsequent biomedical investigations and translational applications.[3]

Publications

The publication record associated with VASANTHA PADMANABHAN demonstrates extensive scholarly productivity in biomedical sciences and endocrinology. Selected research publications include investigations related to developmental physiology, reproductive endocrinology, and translational biomedical science.[6]

  1. Research examining developmental origins of reproductive dysfunction and endocrine disruption.[5]
  2. Studies investigating prenatal exposure models and physiological consequences associated with endocrine pathways.[6]
  3. Collaborative biomedical investigations addressing reproductive health, metabolic regulation, and developmental adaptation.[4]

Representative DOI-linked publications further illustrate the researcher’s contribution to internationally recognized biomedical literature.

Research Impact

The research impact of VASANTHA PADMANABHAN is reflected through extensive citation metrics, broad interdisciplinary engagement, and continued relevance within biomedical sciences literature. Citation performance exceeding 16,000 citations demonstrates sustained academic utilization of the researcher’s work across endocrinology, physiology, reproductive biology, and translational medicine.[1]

The h-index value of 69 further indicates a consistently influential publication profile characterized by both productivity and scholarly recognition.[3] Research findings associated with developmental programming and endocrine health continue to support ongoing biomedical discussions concerning reproductive outcomes, metabolic regulation, and physiological adaptation.

Award Suitability

The scientific achievements and publication record of VASANTHA PADMANABHAN demonstrate strong alignment with the objectives of the Innovative Research Award presented through The Scientist Global Awards. The researcher’s sustained scholarly contributions, interdisciplinary collaborations, and internationally recognized impact in biomedical sciences represent significant indicators of academic excellence and scientific advancement.[2]

The combination of high citation impact, substantial publication output, and continued influence within biomedical and physiological research communities supports recognition within international academic award frameworks dedicated to scientific innovation and research excellence.[4]

Conclusion

VASANTHA PADMANABHAN has established a distinguished research profile within biomedical sciences through extensive scientific publication, influential citation performance, and sustained contributions to reproductive endocrinology and developmental physiology. The scholarly work associated with this profile reflects both scientific rigor and translational relevance, contributing to ongoing advancement in biomedical knowledge and physiological research.[1] The researcher’s achievements and measurable academic influence demonstrate substantial suitability for international recognition through the Innovative Research Award framework.

References

  1. Elsevier. (n.d.). Scopus author details: VASANTHA PADMANABHAN, Author ID 7102543982. Scopus.https://www.scopus.com/authid/detail.uri?authorId=7102543982
  2. ORCID. (n.d.). VASANTHA PADMANABHAN ORCID record. ORCID Foundation.https://orcid.org/0000-0002-8443-7212
  3. Science Advances. (2026). Restoration of ovarian endocrine function with encapsulated immune isolated human ovarian xenograft in ovariectomized mice.https://doi.org/10.1126/sciadv.adx6348
  4. University of Michigan. (n.d.). Faculty and biomedical research overview.https://medicine.umich.edu/
  5. Padmanabhan, V. et al. (2010). Developmental programming of reproductive and metabolic health. Journal of Neuroendocrinology.DOI:https://doi.org/10.1111/j.1365-2826.2010.02073.x
  6. Journal of Clinical Medicine(2024). Changes in Lipid Profiles with the Progression of Pregnancy in Black Women.
    https://doi.org/10.3390/jcm13102795

Antonion Zapatero Gaviria | Biomedical Sciences | Best Paper Award

Prof. Dr. Antonion Zapatero Gaviria | Biomedical Sciences | Best Paper Award

Jefe de Servicio de Medicina Interna | Hospital Universitario de Fuenlabrada | Spain

Dr. Antonio Zapatero-Gaviria is a distinguished Spanish physician, academic, and public health leader recognized for his outstanding contributions to internal medicine, clinical management, and healthcare policy. He currently serves as Professor of Medicine at the Universidad Rey Juan Carlos and has held pivotal leadership positions within the Spanish healthcare system, including Vice-Minister of Public Health and COVID-19 Response for the Community of Madrid, and Director of the IFEMA Field Hospital during the COVID-19 emergency in 2020. With over four decades of medical and academic experience, Dr. Zapatero-Gaviria has made significant contributions to the advancement of internal medicine and clinical governance. He has authored or co-authored more than 148 scientific publications, garnering over 2,200 citations and achieving an h-index of 27 according to Scopus. His research spans a wide range of topics including infectious diseases, COVID-19 pathophysiology, diabetes care, and health systems management, reflecting both national and international collaborations. A former President of the Spanish Society of Internal Medicine (SEMI) and President of the Federation of Spanish Medical Scientific Associations (FACME), he has played a decisive role in shaping medical standards, professional development, and evidence-based healthcare in Spain. His academic excellence is reflected in three research merit recognitions by ANECA and his induction as a full member of the Real Academia Europea de Doctores in 2024. Dr. Zapatero-Gaviria’s work integrates scientific rigor, leadership in health crisis management, and commitment to the modernization of medical care. His influence extends beyond academia, embodying a model of physician-leadership that bridges clinical excellence, policy innovation, and public service for the betterment of healthcare systems and patient outcomes.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Pairo-Castineira, E., Rawlik, K., Bretherick, A. D., Qi, T., Wu, Y., Nassiri, I., … Zapatero-Gaviria, A. (2023). GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature, 617(7962), 764–768. https://doi.org/10.1038/s41586-023-06034-3 — 183 citations

  2. Barba, R., Losa, J. E., Velasco, M., Guijarro, C., de Casasola, G. G., & Zapatero, A. (2006). Mortality among adult patients admitted to the hospital on weekends. European Journal of Internal Medicine, 17(5), 322–324. https://doi.org/10.1016/j.ejim.2006.03.008 — 163 citations

  3. Sanchez-Vazquez, R., Guío-Carrión, A., Zapatero-Gaviria, A., Martínez, P., … (2021). Shorter telomere lengths in patients with severe COVID-19 disease. Aging (Albany NY), 13(1), 1–14. https://doi.org/10.18632/aging.202476 — 122 citations

  4. Zapatero, A., Barba, R., Ruiz, J., Losa, J. E., Plaza, S., Canora, J., & Marco, J. (2013). Malnutrition and obesity: influence in mortality and readmissions in chronic obstructive pulmonary disease patients. Journal of Human Nutrition and Dietetics, 26(Suppl. 1), 16–22. https://doi.org/10.1111/jhn.12044 — 116 citations

  5. Marco, J., Barba, R., Zapatero, A., Matía, P., Plaza, S., Losa, J. E., Canora, J., … (2011). Prevalence of the notification of malnutrition in the departments of internal medicine and its prognostic implications. Clinical Nutrition, 30(4), 450–454. https://doi.org/10.1016/j.clnu.2011.01.008 — 103 citations

Ekadashi Rajni | Biomedical Sciences | Best Researcher Award

Dr. Ekadashi Rajni | Biomedical Sciences | Best Researcher Award

Professor | Mahatma Gandhi Medical College & Hospital | India

Dr. E. Rajni Sabharwal, MD in Microbiology, is a leading researcher in clinical microbiology, antimicrobial resistance (AMR), and infection control. Her research focuses on emerging multidrug-resistant and extensively drug-resistant organisms, epidemiology of hospital-acquired infections, and antimicrobial susceptibility patterns in critical clinical settings, including urinary tract and bloodstream infections. She actively contributes to national multicentric studies on AMR surveillance and the implementation of antimicrobial and diagnostic stewardship programs, integrating One Health approaches. Dr. Sabharwal’s work encompasses molecular characterization of pathogens, synergy testing of novel antibiotic combinations, biofilm studies, and evaluation of rapid diagnostic tools to optimize patient management. Her publications address Gram-negative resistance, carbapenem-resistant Enterobacterales, Stenotrophomonas and MRSA infections, fungal pathogens, and empirical management strategies in tertiary care hospitals. She also investigates the role of immunotherapeutic interventions, such as SPAG9-primed dendritic cell-based vaccines, in gallbladder cancer. With expertise in epidemiological research, laboratory diagnostics, and clinical trial design, she has advanced knowledge on antimicrobial stewardship and resistance mitigation. Through workshops, symposia, and mentorship, Dr. Sabharwal promotes evidence-based practices, bridging clinical microbiology with public health strategies to combat AMR and improve patient outcomes, establishing her as a prominent contributor to infectious disease research and translational microbiology. (210 citations by ; 36 Documents; h-index: 8).

Profiles: Google scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Sabharwal, E. R. (2012). Antibiotic susceptibility patterns of uropathogens in obstetric patients. North American Journal of Medical Sciences, 4(7), 316. Citations: 106

  2. Sabharwal, E. R., & Sharma, R. (2015). Fosfomycin: An alternative therapy for the treatment of UTI amidst escalating antimicrobial resistance. Journal of Clinical and Diagnostic Research, 9(12), DC06–DC09. Citations: 48

  3. Sabharwal, E. R., & Sharma, R. (2015). Estimation of microbial air contamination by settle plate method: Are we within acceptable limit? Scholars Academic Journal of Biosciences, 3(8), 703–707. Citations: 15

  4. Sabharwal, E. R. (2010). Successful management of Trichosporon asahii urinary tract infection with fluconazole in a diabetic patient. Indian Journal of Pathology and Microbiology, 53(2), 387–388. Citations: 14

  5. Jain, M., Sabharwal, E. R., & Srivastava, D. (2016). Practices of health care personnel regarding occupational exposure. Journal of Clinical and Diagnostic Research, 10(11), DC14–DC17. Citations: 12

Shoubhik Chakraborty | Biomedical Sciences | Best Researcher Award

Dr. Shoubhik Chakraborty | Biomedical Sciences | Best Researcher Award

Pediatric Optometrist | Kalinga Institute of Medical Sciences | India

Mr. Shoubhik Chakraborty is a dedicated Clinical Optometrist specializing in Pediatric Optometry, Cerebral Visual Impairment (CVI), Binocular Vision, Neuro-Optometry, and Behavioral Optometry. He completed his Bachelor’s degree in Clinical Optometry and Vision Science (2017–2021) from NSHM College of Management and Technology, MAKAUT University, Durgapur, followed by a Fellowship in Pediatric Optometry, Binocular Vision, and Cerebral Visual Impairment (2021–2023) at Narayana Nethralaya, Bangalore. His academic foundation was built at Karaiya High School and Sagardighi Thermal Power School, affiliated with WBBSE and WBCHSE respectively. Professionally, Mr. Chakraborty began his clinical training at MGM Eye Institute, Raipur, where he gained hands-on experience in hospital-based vision care. He later worked as a Cerebral Visual Impairment Specialist at AIIMS, Jodhpur, demonstrating excellence in managing pediatric and neuro-optometric cases, and is currently serving as a Pediatric Optometrist at KIMS Hospital, Bhubaneswar, where he continues to advance patient outcomes through customized vision therapy and diagnostic precision. His research interests encompass neuro-visual rehabilitation, visual neuroplasticity, binocular dysfunctions, amblyopia management, and pediatric refractive errors. He has developed strong research skills in clinical data interpretation, vision assessment methodologies, and evidence-based optometric intervention design. Mr. Chakraborty has contributed scholarly papers, including publications in Optometry and Visual Performance, and presented his findings at prestigious forums such as the Asia Pacific Optometry Summit (2018), Bengal Optometry Conference (2020), and Karnataka Optometry Conference (2022). Recognized for his leadership, teamwork, and clinical innovation, he exemplifies a balance of academic rigor and compassionate care. His achievements reflect a commitment to advancing pediatric visual science through both clinical excellence and research innovation. With his growing expertise, professional dedication, and vision for future advancements, Mr. Shoubhik Chakraborty is poised to emerge as a leading figure in neuro-visual and pediatric optometry research and practice in India and beyond.

Profiles: Google Scholar | ORCID  | ResearchGate

Featured Publications

  1. Chakraborty, S., Sarbajna, P., Vinekar, A., & Shetty, B. (2024). Outcomes of vision therapy among children with cerebral visual impairment: A retrospective study. Optometry and Visual Performance, 12 (1).

  2. Chakraborty, S., & Parida, S. (2025). Effect of vision therapy on cerebral visual impairment: Insights from three pediatric cases. Advances in Ophthalmology and Visual System (AOVS), 15 (2).

  3. Chakraborty, S. D., & Hajira, R. (2025). Recovering vision and binocularity in a presbyopic patient with amblyopia. Vision Development and Rehabilitation (VDR), 11 (1), 48.

  4. Chakraborty, S., Parida, S., Mohanty, S. K., Das, M., Dash, S., & Mohanty, S. (2025). Prevalence of accommodative insufficiency in children with normal accommodative-convergence/accommodation ratio and its association with refractive error: A cross-sectional study. Cureus, 17 (2).

  5. Chakraborty, S., Parida, S., & Mohanty, S. K. (2025). Effect of vision therapy on cerebral visual impairment: Insights from three pediatric cases. Advances in Ophthalmology and Visual System, 15 (2), 82–85.